Netherlands· NL-6971776334b5

Glusod 25 mg filmomhulde tabletten

A empagliflozin product containing empagliflozine, registered in Netherlands by Medochemie Limited. The same ATC class is registered in 16 of our 19 countries.

ATC A10BK03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about empagliflozineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Empagliflozin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BK03 (empagliflozin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search empagliflozin products by name

Empagliflozin · ATC A10BK03

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of empagliflozin costs, country by country.

Normalised to the WHO defined daily dose (17.5 mg), so markets compare like for like.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Empagliflozin · price per daily dose (17.5 mg)

USD · FX 28 Sept 2026

CH Switzerland$3.80
IT Italy$2.95

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: EMPAGLIFLOZINE
Manufacturer: Medochemie Limited
Country: Netherlands (NL)
ATC code: A10BK03
ATC class: Empagliflozin
Defined daily dose: 17.5 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
130420

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

466 interactions on record for empagliflozin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check empagliflozin against other medicines How interaction checks work

Empagliflozin · interactions on record

466 records

1 severe
425 moderate
40 minor

Most severe, free to view

SucralfateA02BX02moderate
PapaverineA03AD01moderate
ThiethylperazinA04AB03moderate
TriflupromazinA04AD06moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Empagliflozin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All empagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Empagliflozin Denk, Empagliflozin Devatis
Belgium · Empagliflozin Ab, Empagliflozine Hcs
Bulgaria · Глузод, Емлигекса
Cyprus · Glusod
Czechia · Empagliflozin Polpharma, Empelic
Germany · Empagliflozin Devatis, Emprables
Denmark · Bifoglan, Elemio
Estonia · Glusod
Spain · Empagliflozina Aurovitas, Empagliflozina Kern Pharma
Finland · Empagliflozin Devatis, Empagliflozin Reddy
United Kingdom (Northern Ireland) · Empagliflozin, Empagliflozin G.L. Pharma
Greece · Elemio, Empagliflozin Pharmapath
Croatia · Glusod
Hungary · Empagliflozin Polpharma
Ireland · Empagliflozin Krka
Iceland · Empagliflozin Reddy, Empagliflozin Wh 10 Mg
Liechtenstein · Jardiance
Lithuania · Embeflyx, Emlygexa
Luxembourg · Empagliflozin Ab
Latvia · Embeflyx, Emlygexa
Malta · Empagliflozin Denk, Eprekavor
Norway · Empagliflozin Devatis, Empagliflozin Reddy
Poland · Empelic
Portugal · Empagliflozina Aurobindo, Empagliflozina Aurovitas
Romania · Glusod
Sweden · Empagliflozin Devatis, Empagliflozin Labiana
Slovenia · Empagliflozin Krka, Glusod
Slovakia · Empagliflozin Polpharma, Glusod

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/aa72fa42-5281-43cb-862f-ca199c5d8fd6
GET /v1/drugs/aa72fa42-5281-43cb-862f-ca199c5d8fd6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h130420_smpc_en.pdf",
  "strength": null,
  "atc_label": "Empagliflozin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130420",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "EMPAGLIFLOZINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130420_piluk.pdf",
  "authorised_at": "2024/03/19",
  "procedure_number": "NL/H/5639/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "130420",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about empagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console